Literature DB >> 15475765

Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients.

Mansour A Parsi1, Bret A Lashner.   

Abstract

Entities:  

Year:  2004        PMID： 15475765     DOI： 10.1097/00054725-200407000-00028

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas.

Authors:  Hector Guadalajara; Dolores Herreros; Paloma De-La-Quintana; Jacobo Trebol; Mariano Garcia-Arranz; Damian Garcia-Olmo
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

Review 2.  Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis.

Authors:  A Waljee; J Waljee; A M Morris; P D R Higgins
Journal:  Gut       Date:  2006-06-13       Impact factor: 23.059

3.  Adipose-derived stem cells in Crohn's rectovaginal fistula.

Authors:  D García-Olmo; D Herreros; P De-La-Quintana; H Guadalajara; J Trébol; T Georgiev-Hristov; M García-Arranz
Journal:  Case Rep Med       Date:  2010-03-07

4.  Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis.

Authors:  Parambir S Dulai; Siddharth Singh; Vipul Jairath; Christopher Ma; Neeraj Narula; Niels Vande Casteele; Laurent Peyrin-Biroulet; Severine Vermeire; Geert D'Haens; Brian G Feagan; William J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2019-11-22       Impact factor: 8.171
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.